Sageworth Trust Company of South Dakota’s Medifast MED Stock Holding History

Sageworth Trust Company of South Dakota’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-14	Closed	-$1.45K	–	135
2023 Q1	$1.45K	Hold	14	–	–	﹤0.01%	202
2022 Q4	$2K	Hold	14	–	–	﹤0.01%	209
2022 Q3	$2K	Sell	14 -5	-26%	-$716	﹤0.01%	197
2022 Q2	$3K	Sell	19 -8	-30%	-$1.43K	0.01%	313
2022 Q1	$5K	Hold	27	–	–	0.01%	291
2021 Q4	$6K	Buy	+27	New	+$5.58K	0.01%	491

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sageworth Trust Company of South Dakota's MED Position: Q2 2023 in Review

Sageworth Trust Company of South Dakota sold out of Medifast (MED) in Q2 2023, closing a stake of 14 shares — an estimated $1.45K sold.

Sageworth Trust Company of South Dakota first reported a position in MED in Q4 2021 and held it in 6 quarters. The position peaked at $6K in Q4 2021. 236 funds tracked by Wall St. Rank hold MED as of Q2 2023.

Sageworth Trust Company of South Dakota reported no remaining Medifast position as of Q2 2023 after selling out during the quarter.
Sageworth Trust Company of South Dakota sold 14 Medifast shares in Q2 2023, an estimated $1.45K.
Sageworth Trust Company of South Dakota first reported a position in Medifast in Q4 2021 and held it in 6 quarters.
Sageworth Trust Company of South Dakota's Medifast position peaked at $6K in Q4 2021.
236 funds tracked by Wall St. Rank held Medifast as of Q2 2023.

Based on Sageworth Trust Company of South Dakota's 13F filing for Q2 2023, filed 3 Aug 2023.